| Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection J Fantini, C Di Scala, H Chahinian, N Yahi International journal of antimicrobial agents 55 (5), 105960, 2020 | 678 | 2020 |
| How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains J Fantini, FJ Barrantes Frontiers in physiology 4, 31, 2013 | 556 | 2013 |
| CH–π hydrogen bonds in biological macromolecules M Nishio, Y Umezawa, J Fantini, MS Weiss, P Chakrabarti Physical Chemistry Chemical Physics 16 (25), 12648-12683, 2014 | 487 | 2014 |
| Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative … J Fantini, DG Cook, N Nathanson, SL Spitalnik, F Gonzalez-Scarano Proceedings of the National Academy of Sciences 90 (7), 2700-2704, 1993 | 336 | 1993 |
| Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases J Fantini, N Garmy, R Mahfoud, N Yahi Expert reviews in molecular medicine 4 (27), 1-22, 2002 | 321 | 2002 |
| Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells N Yahi, S Baghdiguian, H Moreau, J Fantini Journal of virology 66 (8), 4848-4854, 1992 | 303 | 1992 |
| The mycotoxin deoxynivalenol affects nutrient absorption in human intestinal epithelial cells M Maresca, R Mahfoud, N Garmy, J Fantini The Journal of nutrition 132 (9), 2723-2731, 2002 | 300 | 2002 |
| The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione R Mahfoud, M Maresca, N Garmy, J Fantini Toxicology and applied pharmacology 181 (3), 209-218, 2002 | 291 | 2002 |
| Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins R Mahfoud, N Garmy, M Maresca, N Yahi, A Puigserver, J Fantini Journal of Biological Chemistry 277 (13), 11292-11296, 2002 | 285 | 2002 |
| Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function J Fantini, FJ Barrantes Biochimica et Biophysica Acta (BBA)-Biomembranes 1788 (11), 2345-2361, 2009 | 275 | 2009 |
| Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor CJ Baier, J Fantini, FJ Barrantes Scientific reports 1 (1), 69, 2011 | 258 | 2011 |
| Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases M Maresca, J Fantini Toxicon 56 (3), 282-294, 2010 | 228 | 2010 |
| Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseases J Fantini, N Yahi Expert Reviews in Molecular Medicine 12, e27, 2010 | 200 | 2010 |
| Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: Stimulation of interleukin-8 … M Maresca, N Yahi, L Younès-Sakr, M Boyron, B Caporiccio, J Fantini Toxicology and Applied Pharmacology 228 (1), 84-92, 2008 | 199 | 2008 |
| Common molecular mechanism of amyloid pore formation by Alzheimer’s β-amyloid peptide and α-synuclein C Di Scala, N Yahi, S Boutemeur, A Flores, L Rodriguez, H Chahinian, ... Scientific reports 6 (1), 28781, 2016 | 194 | 2016 |
| Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3 D Hammache, G Piéroni, N Yahi, O Delézay, N Koch, H Lafont, C Tamalet, ... Journal of Biological Chemistry 273 (14), 7967-7971, 1998 | 165 | 1998 |
| Interaction of Alzheimer’s β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation C Di Scala, H Chahinian, N Yahi, N Garmy, J Fantini Biochemistry 53 (28), 4489-4502, 2014 | 162 | 2014 |
| Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 … D Hammache, N Yahi, M Maresca, G Piéroni, J Fantini Journal of Virology 73 (6), 5244-5248, 1999 | 159 | 1999 |
| Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry J Fantini, D Hammache, O Delézay, N Yahi, C André-Barrès, I Rico-Lattes, ... Journal of Biological Chemistry 272 (11), 7245-7252, 1997 | 157 | 1997 |
| Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop DG Cook, J Fantini, SL Spitalnik, F Gonzalez-Scarano Virology 201 (2), 206-214, 1994 | 150 | 1994 |